Earnings NewsHealthcareXenon Pharma GAAP EPS of -$1.77 misses by $1.41, revenue of $18.43M beats by $12.13MMar. 01, 2022 4:06 PM ETXenon Pharmaceuticals Inc. (XENE)By: Urvi Shah, SA News Editor Xenon Pharma press release (NASDAQ:XENE): Q4 GAAP EPS of -$1.77 misses by $1.41. Revenue of $18.43M (-42.7% Y/Y) beats by $12.13M. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsCatalyst Watch: McDonald's event, Lululemon earnings and GameStop volatility reduxCrypto-tied stocks top financial gainers for second straight weekMaterials Sector Weekly Round-up: Gold stocks top list; Franco-Nevada at bottomCharles Schwab files for mixed shelfBoeing eliminated from Air Force 'doomsday plane' competitionSee More »About XENESymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgXENE--Xenon Pharmaceuticals Inc.ZLAB--Zai Lab LimitedBHVN--Biohaven Ltd.NTLA--Intellia Therapeutics, Inc.MLTX--MoonLake ImmunotherapeuticsCompareTrending AnalysisTrending News